Titre :
  • Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH.
Auteur : Desmedt, Christine ; Sperinde, Jeff ; Piette, Fanny ; Huang, Weidong ; Jin, Xueguang ; Tan, Yuping ; Durbecq, Virginie ; Larsimont, Denis ; Giuliani, Rosa ; Chappey, Colombe ; Buyse, Marc ; Winslow, John ; Piccart-Gebhart, Martine ; Sotiriou, Christos ; Petropoulos, Christos ; Bates, Jessica
Informations sur la publication : Diagnostic molecular pathology, 18, 1, (page 22-29)
Statut de publication : Publié, 2009-03
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- therapeutic use
Breast -- chemistry
Breast Neoplasms -- drug therapy
Breast Neoplasms -- mortality
Breast Neoplasms -- pathology
Breast Neoplasms -- secondary
Cohort Studies
Female
Humans
In Situ Hybridization, Fluorescence -- methods
Middle Aged
Protein Multimerization
Receptor, erbB-2 -- analysis
Survival Analysis
Treatment Outcome
Note : Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1052-9551 
info:doi/10.1097/PDM.0b013e31818ebc69
info:pmid/19214112